ArticleBMC cancer2015

Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer.

Jianzhang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.